The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

A.D. Kaprin

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of Ministry of Russia;
Peoples’ Friendship University of Russia

S.A. Ivanov

Tsyb Medical Radiology Research Center

V.M. Unguryan

Kostroma Oncology Center

A.N. Kazantsev

St. Petersburg City Alexandrovskaya Hospital

Yu.V. Belov

Petrovsky National Research Center of Surgery;
Sechenov First Moscow State Medical University

Isolated liver perfusion with melphalan followed by pembrolizumab therapy for unresectable metastases of uveal melanoma to the liver

Authors:

A.D. Kaprin, S.A. Ivanov, V.M. Unguryan, A.N. Kazantsev, Yu.V. Belov

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2023;(7): 94‑99

Views: 811

Downloaded: 4


To cite this article:

Kaprin AD, Ivanov SA, Unguryan VM, Kazantsev AN, Belov YuV. Isolated liver perfusion with melphalan followed by pembrolizumab therapy for unresectable metastases of uveal melanoma to the liver. Pirogov Russian Journal of Surgery. 2023;(7):94‑99. (In Russ.)
https://doi.org/10.17116/hirurgia202307194

Recommended articles:
Surgical treatment for meta­stases of uveal mela­noma in the liver. P.A. Herzen Journal of Onco­logy. 2023;(5):52-57

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.